Skip to content

Study · Not a test of the peptide alone · 2019

1 result

A multimodal pharmacological agent in combination with recanalization therapy (thrombolysis and thrombectomy) in severe stroke patients.

Poljakovic Z, Ljevak J, Supe S, Starcevic K

Journal of medicine and life1 Oct 2019

PMID32025269 (opens in a new tab)PMCIDPMC6993298 (opens in a new tab)DOI10.25122/jml-2019-1011 (opens in a new tab)PepBankPUB-32025269
Download PDFPubMedAsk about this study
Jump to 1 result

Summary

This case report highlights a case of large ischemic stroke and indication for anticoagulant therapy treated with thrombolysis and pharmacological intervention for neurological recovery with a multimodal agent (Cerebrolysin) as add-on therapy to recanalization techniques, including IV thrombolysis. We observed a significant clinical improvement after one year of follow-up. Based on our experience, we can assert that Cerebrolysin can be safely administered in stroke patients, even in complicated cases, with a good chance for improvement of their clinical status.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In a severe ischemic stroke case, Cerebrolysin with recanalization therapy was followed by significant clinical improvement after one year.

    In plain wordsIn a stroke case, Cerebrolysin with recanalization therapy was followed by significant clinical improvement after one year.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseClinical improvement
    Study

    n = 1

    Outcome group
    Neuroprotection · Nervous system and cognition

    Source sentences

    Summary
    We observed a significant clinical improvement after one year of follow-up.
    1 context sentence
    Summary · context
    This case report highlights a case of large ischemic stroke and indication for anticoagulant therapy treated with thrombolysis and pharmacological intervention for neurological recovery with a multimodal agent (Cerebrolysin) as add-on therapy to recanalization techniques, including IV thrombolysis.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.